According to the SEC Form 4 filings, GUTKOWSKI ROBERT M, being in a position of
No biography is available at this moment.
Buys | $0 | 0 | 0 |
Sells | $351,503 | 1 | 100 |
| 2025-11-14 | ACV Auctions Inc. ACVA | director | 80,571 0.0456% | $6.21 | $500,346 | +0.48% | ||
| 2025-11-14 | Sale | Akamai Technologies, Inc. AKAM | Chief Technology Officer | 3,000 0.0021% | $87.68 | $263,051 | -0.59% | |
| 2025-11-14 | Sale | Apogee Therapeutics, Inc. APGE | Chief Financial Officer | 2,000 0.0038% | $65.00 | $130,000 | +0.77% | |
| 2025-11-14 | Sale | AppFolio, Inc. APPF | General Counsel | 334 0.0009% | $243.67 | $81,386 | +1.76% | |
| 2025-11-14 | Sale | Arlo Technologies, Inc. ARLO | GENERAL COUNSEL | 149,521 0.1385% | $14.37 | $2.15M | -1.62% | |
| 2025-11-14 | Sale | BKV Corporation BKV | Chief Executive Officer | 21,719 0.027% | $28.00 | $608,202 | -0.19% | |
| 2025-11-14 | Centuri Holdings, Inc. CTRI | 10 percent owner | 3.49M 4.0403% | $21.50 | $75M | -2.93% | ||
| 2025-11-14 | CVB Financial Corp. CVBF | director | 27,094 0.0195% | $18.45 | $499,995 | +2.2% | ||
| 2025-11-14 | Sale | DraftKings Inc. DKNG | Chief Financial Officer | 8,421 0.0017% | $29.23 | $246,146 | +1.2% | |
| 2025-11-14 | Sale | Dianthus Therapeutics, Inc. DNTH | EVP, Head of R&D | 109,031 0.3235% | $38.14 | $4.16M | +7.11% | |
| 2025-11-14 | The Eastern Company EML | director | 762 0.0122% | $19.47 | $14,836 | +0.1% | ||
| 2025-11-14 | Sale | Entravision Communications Corporation EVC | 10 percent owner | 46,064 0.0491% | $2.77 | $127,491 | +2.97% | |
| 2025-11-14 | FTAI Aviation Ltd. FTAI | Chief Financial Officer | 652 0.0006% | $153.46 | $100,056 | +3.15% | ||
| 2025-11-14 | First US Bancshares, Inc. FUSB | director | 500 0.0083% | $13.43 | $6,715 | -0.15% | ||
| 2025-11-14 | Sale | GigaCloud Technology Inc. GCT | Chief Operating Officer | 30,000 0.0787% | $30.42 | $912,597 | +<0.01% | |
| 2025-11-14 | Sale | Janux Therapeutics, Inc. JANX | Chief Business Officer | 3,333 0.0061% | $30.00 | $99,990 | -2.4% | |
| 2025-11-14 | Sale | Kura Oncology, Inc. KURA | Chief Operating Officer | 6,902 0.0083% | $11.18 | $77,143 | +0.25% | |
| 2025-11-14 | Sale | Kura Oncology, Inc. KURA | SVP, Finance & Accounting | 4,539 0.0055% | $11.18 | $50,732 | +0.25% | |
| 2025-11-14 | Sale | Kura Oncology, Inc. KURA | Chief Commercial Officer | 8,887 0.0107% | $11.18 | $99,329 | +0.25% | |
| 2025-11-14 | Sale | Kura Oncology, Inc. KURA | Chief Legal Officer | 8,804 0.0106% | $11.18 | $98,401 | +0.25% |